Abstract: Systems, methods, and apparatus are provided for intelligent, integrated, and interactive remote reporting. A remote natural language request for a report may be received from a user at an edge device. A first machine learning model may generate a list of existing reports based on past usage by the user. If no existing report satisfies the request, a second, enterprise-level machine learning model may map the request to relevant data sets and rank the mapped data sets along with additional related data sets based on enterprise-wide usage. An integrated reporting platform may receive selected data sets and report parameters as a JSON request, convert the request to compatible executable instructions, and generate the report. The integrated reporting platform may be a wrapper layer encompassing multiple proprietary reporting engines. Feedback from the integrated reporting platform may be applied to update the machine learning models.

Abstract: Disclosed herein is a method against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The method includes administering to a subject in need thereof a first active ingredient selected from the group consisting of methotrexate (MIX) and a pharmaceutically acceptable salt thereof, and a second active ingredient selected from the group consisting of remdesivir and a pharmaceutically acceptable salt thereof. A molar ratio of the first active ingredient to the second active ingredient ranges from 1:13 to 1:25.

Abstract: Systems, methods, and apparatus are provided for fraud screening via smart glasses interactions during an ATM session. A smart glasses device may capture an image of an ATM environment. The ATM and the smart glasses device may be edge nodes on an edge network. An edge platform may use a fraud detection model to classify the image and compare it to stored ATM images. The model may be trained at an enterprise server and stored on the edge platform. In response to a determination of fraud at the edge platform, a fraud alert may be transmitted to the smart glasses device during the ATM session. Edge computing reduces latency to enable real-time smart glasses alerts. The smart glasses device may communicate the fraud alert to other smart glasses devices on the edge network.

Abstract: Systems, methods, and apparatus are provided for intelligent, integrated, and interactive remote reporting. A remote natural language request for a report may be received from a user at an edge device. A first machine learning model may generate a list of existing reports based on past usage by the user. If no existing report satisfies the request, a second, enterprise-level machine learning model may map the request to relevant data sets and rank the mapped data sets along with additional related data sets based on enterprise-wide usage. An integrated reporting platform may receive selected data sets and report parameters as a JSON request, convert the request to compatible executable instructions, and generate the report. The integrated reporting platform may be a wrapper layer encompassing multiple proprietary reporting engines. Feedback from the integrated reporting platform may be applied to update the machine learning models.

Abstract: Systems, methods, and apparatus are provided for fraud screening via smart glasses interactions during an ATM session. A smart glasses device may capture an image of an ATM environment. The ATM and the smart glasses device may be edge nodes on an edge network. An edge platform may use a fraud detection model to classify the image and compare it to stored ATM images. The model may be trained at an enterprise server and stored on the edge platform. In response to a determination of fraud at the edge platform, a fraud alert may be transmitted to the smart glasses device during the ATM session. Edge computing reduces latency to enable real-time smart glasses alerts. The smart glasses device may communicate the fraud alert to other smart glasses devices on the edge network.

Abstract: Disclosed herein is a method against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The method includes administering to a subject in need thereof a first active ingredient selected from the group consisting of methotrexate (MIX) and a pharmaceutically acceptable salt thereof, and a second active ingredient selected from the group consisting of remdesivir and a pharmaceutically acceptable salt thereof. A molar ratio of the first active ingredient to the second active ingredient ranges from 1:13 to 1:25.